Schalop Lee Troy bought LTRN
August 19, 2025 · Form 4 insider transaction
Schalop Lee Troy bought 5,000 shares of Lantern Pharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$0.00
Total value
N/A
InsiderSchalop Lee Troy
Role—
CompanyLantern Pharma Inc. (LTRN)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 19, 2025
Filing dateAugust 20, 2025
Shares owned after5,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Equity Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing September 19, 2025.